Skip to Main Content

Paper Details

A multilevel mHealth intervention boosts adherence to hydroxyurea in individuals with sickle cell disease.
Blood Adv
2
2023
HbF, HbS0, HbSS, Hydroxyurea, SCD, advanced, hydroxyurea, participants, patient, patients, sickle cell disease
Author NameAffiliation
Jane S HankinsSt. Jude Children's Research Hospital
Jane S HankinsCenter for Sickle Cell Disease, University of Tennessee Health Science Center
Jane S HankinsSt. Jude Children's Research Hospital
Victor R GordeukUniversity of Illinois at Chicago
Hayden B BosworthDuke University
Hayden B BosworthCenter of Innovation to Accelerate Discovery and Practice Transformation Durham Veterans Affairs Medical Center
Nirmish ShahDuke University
  • 1 - 7

Datasets

Release 1.2